Similar articles

• Postconditioning the human heart with adenosine in heart valve replacement surgery.

  Jin ZX, Zhou JJ, Xin M, Peng DR, Wang XM, Bi SH, Wei XF, Yi DH. Jin ZX, et al. Ann Thorac Surg. 2007 Jun;83(6):2066-72. doi: 10.1016/j.athoracsur.2006.12.031. Ann Thorac Surg. 2007. PMID: 17532398 Clinical Trial.
• Anesthesia management for retrograde aortic valve replacement.

  Fassl J, Kodavatiganti R, Ingerski MS. Fassl J, et al. Can J Anaesth. 2009 Apr;56(4):336; author reply 337. doi: 10.1007/s12630-009-9064-3. Epub 2009 Feb 27. Can J Anaesth. 2009. PMID: 19247735 No abstract available.
• Invited commentary.

  Krukenkamp I. Krukenkamp I. Ann Thorac Surg. 2007 Jun;83(6):2073. doi: 10.1016/j.athoracsur.2007.01.015. Ann Thorac Surg. 2007. PMID: 17532399 No abstract available.
• Myocardial protection with blood cardioplegia during valve operations.

  Beyersdorf F, Buckberg GD. Beyersdorf F, et al. J Heart Valve Dis. 1994 Jul;3(4):388-403. J Heart Valve Dis. 1994. PMID: 7952313 Review. No abstract available.
• [Prevention of thromboembolism in heart valve diseases and following heart valve replacement].

  Stenzinger W, van de Loo J. Stenzinger W, et al. Internist (Berl). 1989 Aug;30(8):520-4. Internist (Berl). 1989. PMID: 2676892 Review. German. No abstract available.